GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Alcon Inc (NYSE:ALC) » Definitions » Short-Term Debt

Alcon (ALC) Short-Term Debt : $135 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Alcon Short-Term Debt?

Alcon's Short-Term Debt for the quarter that ended in Dec. 2023 was $135 Mil.

Alcon's quarterly Short-Term Debt stayed the same from Jun. 2023 ($0 Mil) to Sep. 2023 ($0 Mil) but then increased from Sep. 2023 ($0 Mil) to Dec. 2023 ($135 Mil).

Alcon's annual Short-Term Debt declined from Dec. 2021 ($107 Mil) to Dec. 2022 ($97 Mil) but then increased from Dec. 2022 ($97 Mil) to Dec. 2023 ($135 Mil).

Alcon Short-Term Debt Historical Data

The historical data trend for Alcon's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alcon Short-Term Debt Chart

Alcon Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial 245.00 162.00 107.00 97.00 135.00

Alcon Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 97.00 - - - 135.00

Alcon Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Alcon Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Alcon's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Alcon (ALC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Alcon Inc (NYSE:ALC) » Definitions » Short-Term Debt
Comparable Companies
XSWX:STMN XSWX:YPSN XSWX:TECN XSWX:SKAN XSWX:CLTN XSWX:VBSN ISRG XPAR:EL BDX TSE:7741 WST OCSE:COLO B RMD TSE:4543 BAX XPAR:DIM HOLX TSE:7733 COO TSE:6869
Traded in Other Exchanges
ALC:Mexico ALCz:UK 0A0D:UK ALC:Switzerland
Address
Chemin de Blandonnet 8, Royce Bedward, Vernier, Geneva, CHE, 1214
Website
https://www.alcon.com
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.